Cargando…

Does Losartan Prevent Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes?

Detalles Bibliográficos
Autores principales:	Nicholas, Susanne B., Iyengar, Sudha K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749328/ https://www.ncbi.nlm.nih.gov/pubmed/23970520 http://dx.doi.org/10.2337/db13-0748

Ejemplares similares

Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes
por: Weil, E. Jennifer, et al.
Publicado: (2013)

Erratum. Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes. Diabetes 2013;62:3224–3231
por: Weil, E. Jennifer, et al.
Publicado: (2018)

Losartan and diabetic nephropathy: commentaries on the RENAAL study
por: Fisman, Enrique Z, et al.
Publicado: (2002)

Preventing Diabetes in American Indian Communities
por: Knowler, William C., et al.
Publicado: (2013)

Urinary adiponectin and progression of diabetic nephropathy in type 1 diabetes
por: Ha, Kyoung Hwa, et al.
Publicado: (2015)

Effects of Spironolactone and Losartan on Diabetic Nephropathy in a Type 2 Diabetic Rat Model
por: Lee, Mi Young, et al.
Publicado: (2011)

Effect of Spironolactone on Diabetic Nephropathy Compared to the Combination of Spironolactone and Losartan
por: Makhlough, Atieh, et al.
Publicado: (2014)

Effect of losartan and spironolactone on triglyceride-rich lipoproteins in diabetic nephropathy
por: Srivastava, Anand, et al.
Publicado: (2016)

How Does Pioglitazone Prevent Progression of Impaired Glucose Tolerance to Diabetes?
por: Genuth, Saul M.
Publicado: (2013)

Epidermal growth factor receptor signaling and the progression of diabetic nephropathy
por: Koya, Daisuke
Publicado: (2015)

Epigenetic regulation of core genes linking to diabetic nephropathy progression: Lesson from FinnDiane type 1 diabetes study
por: Makino, Hirofumi, et al.
Publicado: (2023)

Combined effect of hydrogen sulphide donor and losartan in experimental diabetic nephropathy in rats
por: Kaur, Manpreet, et al.
Publicado: (2015)

Mitochondrial reactive oxygen species in the pathogenesis of early diabetic nephropathy
por: Nishikawa, Takeshi, et al.
Publicado: (2015)

Selecting SNPs informative for African, American Indian and European Ancestry: application to the Family Investigation of Nephropathy and Diabetes (FIND)
por: Williams, Robert C., et al.
Publicado: (2016)

A commentary on the VITAL study: Does vitamin D (receptor activation) protect against nephropathy in type 2 diabetes?
por: Okada, Shinichi, et al.
Publicado: (2011)

Erratum to: Combined effect of hydrogen sulphide donor and losartan in experimental diabetic nephropathy in rats
por: Kaur, Manpreet, et al.
Publicado: (2015)

Impact of Baseline Renal Function on the Efficacy and Safety of Aliskiren Added to Losartan in Patients With Type 2 Diabetes and Nephropathy
por: Persson, Frederik, et al.
Publicado: (2010)

The Challenging Search for Diabetic Nephropathy Genes
por: Bowden, Donald W., et al.
Publicado: (2012)

Markers of endothelial dysfunction and inflammation predict progression of diabetic nephropathy in African Americans with type 1 diabetes
por: Roy, Monique S., et al.
Publicado: (2014)

Diabetic Nephropathy: Emerging Biomarkers for Risk Assessment
por: Badal, Shawn S., et al.
Publicado: (2015)

Vitamin D in diabetic nephropathy
por: Prabhu, RA, et al.
Publicado: (2018)

A Diabetes Prevention Assessment Tool for American Indians
por: Taylor, Christopher A, et al.
Publicado: (2005)

Young-onset diabetes: An Indian perspective
por: Dutta, Deep, et al.
Publicado: (2019)

Nrf2 Activators as Attractive Therapeutics for Diabetic Nephropathy
por: de Haan, Judy B.
Publicado: (2011)

Values and Limitations of Targeting lncRNAs in Diabetic Nephropathy
por: Long, Jianyin, et al.
Publicado: (2018)

Inhibiting MicroRNA-503 and MicroRNA-181d with Losartan Ameliorates Diabetic Nephropathy in KKAy Mice
por: Zhu, XinWang, et al.
Publicado: (2016)

Bilirubin: A Potential Biomarker and Therapeutic Target for Diabetic Nephropathy
por: Hull, Travis D., et al.
Publicado: (2014)

CREDENCE: A silver lining in the dark cloud of diabetic nephropathy
por: Hanai, Ko, et al.
Publicado: (2019)

G-CSF Prevents Progression of Diabetic Nephropathy in Rat
por: So, Byung-Im, et al.
Publicado: (2013)

Diabetic nephropathy among Mexican Americans
por: Debnath, Subrata, et al.
Publicado: (2012)

Cherokee Choices: A Diabetes Prevention Program for American Indians
por: Bachar, Jeffrey J, et al.
Publicado: (2006)

Advancing Diabetes Prevention and Control in American Indians and Alaska Natives
por: Lucero, Julie E., et al.
Publicado: (2022)

The Role of Dyslipidemia Control in the Progression of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus
por: Chatziralli, Irini P.
Publicado: (2017)

Evidence of Early Diabetic Nephropathy in Pediatric Type 1 Diabetes
por: Mamilly, Leena, et al.
Publicado: (2021)

Primary Prevention of Type 2 Diabetes: There Are No Simple Solutions!
por: Cefalu, William T.
Publicado: (2009)

Combined intervention for the tertiary prevention of type 1 diabetes
por: Kawasaki, Eiji
Publicado: (2015)

The effect of crocin and losartan on TGF-β gene expression and histopathology of kidney tissue in a rat model of diabetic nephropathy
por: Mohammadi, Yaser, et al.
Publicado: (2023)

Tetrahydrocurcumin Add‐On therapy to losartan in a rat model of diabetic nephropathy decreases blood pressure and markers of kidney injury
por: Khazaeli, Mahyar, et al.
Publicado: (2023)

Translating the Diabetes Prevention Program Into American Indian and Alaska Native Communities: Results from the Special Diabetes Program for Indians Diabetes Prevention demonstration project
por: Jiang, Luohua, et al.
Publicado: (2013)

Long-term Outcomes of Lifestyle Intervention to Prevent Diabetes in American Indian and Alaska Native Communities: The Special Diabetes Program for Indians Diabetes Prevention Program
por: Jiang, Luohua, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_uio1jmmd6o852v0oh4083qluec